Journey Medical Corp expected to post a loss of 45 cents a share - Earnings Preview

Journey Medical

10/05/2023 03:06

* Journey Medical Corp  DERM.OQ   DERM.O  is expected
to show a
fall in quarterly revenue when it reports  results on May 11. 
    * The Scottsdale Arizona-based  company is expected to
report  a
30.6% decrease in revenue to $16.177 million from $23.3 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Journey Medical
Corp is
for a loss of 45 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Journey
Medical
Corp is $6​, above​ its last closing price of $1.69. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022              -0.47      -0.60     Missed  -28.6
 Sep. 30 2022  -0.50       -0.40      -0.57     Missed  -43.7
 Jun. 30 2022  -0.26       -0.26      -0.43     Missed  -67.5​
 Mar. 31 2022  -0.31       -0.31      -0.08     Beat    74.2
 ​​Dec.        -0.45       -0.41      -1.64     Missed  -296.8
 31 2021                                                
                                                        ​
 This summary was machine generated May 10 at 02:06 GMT.  All
figures in US dollars  unless otherwise stated